AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022
July 12 2022 - 4:05PM
Business Wire
AbCellera (Nasdaq: ABCL) will announce its second quarter 2022
financial results on Tuesday, August 9, 2022, and hold an earnings
conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
the same day.
A live audio webcast of the earnings conference may be accessed
through a link that will be posted on AbCellera’s Investor
Relations website. A replay will be available through the same link
following the conference call.
About AbCellera Biologics Inc. AbCellera is a technology
company that searches, decodes, and analyzes natural immune systems
to find antibodies that its partners can develop into drugs to
prevent and treat disease. AbCellera partners with drug developers
of all sizes, from large pharmaceutical to small biotechnology
companies, empowering them to move quickly, reduce cost, and tackle
the toughest problems in drug development. For more information,
please visit www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220712005059/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon; bd@abcellera.com, +1(604)559-9005 Investor Relations:
Melanie Solomon; ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Apr 2023 to Apr 2024